AMANDA SELLERS: Open Payments
NPI 1144868969 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 45 payments from 7 companies in 2025. Trend: 2023 $1,055 · 2024 $535 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 36 | $415 |
| PFIZER INC. | 3 | $67 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| Boston Scientific Corporation | 1 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: LEQVIO, VYNDAQEL, AMVUTTRA, WATCHMAN FLX, Kerendia, Wegovy, CAMZYOS, ELIQUIS.
Industry payments across MO — which companies pay providers there.
